RxDoctor Payments Data

LEVEL ONE THORACIC QTY:002: cost and payments to doctors

What Medicare Part D paid pharmacies for LEVEL ONE THORACIC QTY:002, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 20192025.

Was your doctor paid by Kls-martin L.p.?

Kls-martin L.p. reported the most payments naming LEVEL ONE THORACIC QTY:002. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$42K
Providers
0
Transactions
21
Average per transaction
$2,000

The per-transaction average — $2,000 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.

Companies reporting these payments

CompanyTotal reportedShare
Kls-martin L.p.$42,006100.0%

Other products from Kls-martin L.p.

The company that reported the most payments naming LEVEL ONE THORACIC QTY:002 also reports against these.

← All drugs & devices